Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,514
datasets available to search
ShareScore release 0.9.0
Dataset results
3,514 results for “cell therapy”
Adoptive Cell Therapy Across Cancer Diagnoses
ClinicalTrials.gov study NCT03296137. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT00965718. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethason
ClinicalTrials.gov study NCT04181827. IPD Sharing: YES. Countries: 16. Publications: 8.
Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemother
ClinicalTrials.gov study NCT01118091. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02453282. IPD Sharing: YES. Countries: 17. Publications: 2.
Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
ClinicalTrials.gov study NCT00084747. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study
ClinicalTrials.gov study NCT00273364. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lym
ClinicalTrials.gov study NCT00104858. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus Patients
ClinicalTrials.gov study NCT07144241. IPD Sharing: NO. Countries: 1. Publications: 6.
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00103116. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes
ClinicalTrials.gov study NCT00837759. IPD Sharing: Not stated. Countries: 1. Publications: 3.
An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma
ClinicalTrials.gov study NCT03029780. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
ClinicalTrials.gov study NCT02973789. IPD Sharing: UNDECIDED. Countries: 18. Publications: 10.
A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT01310036. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation
ClinicalTrials.gov study NCT01841632. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib
ClinicalTrials.gov study NCT02759835. IPD Sharing: YES. Countries: 1. Publications: 2.
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
ClinicalTrials.gov study NCT01649180. IPD Sharing: NO. Countries: 1. Publications: 4.
Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00255723. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma
ClinicalTrials.gov study NCT00245011. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Autologous Cell Therapy for Treatment of Fecal Incontinence
ClinicalTrials.gov study NCT01600755. IPD Sharing: NO. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.